前收市價 | 1.9050 |
開市 | 2.0000 |
買盤 | 2.1200 x 4900 |
賣出價 | 2.1500 x 3600 |
今日波幅 | 1.9607 - 2.1800 |
52 週波幅 | 1.1600 - 13.6700 |
成交量 | |
平均成交量 | 10,047,885 |
市值 | 581.48M |
Beta 值 (5 年,每月) | 2.04 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -1.1400 |
業績公佈日 | 2024年8月07日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 3.33 |
Pacific Biosciences of California (PACB) concluded the recent trading session at $1.88, signifying a +1.62% move from its prior day's close.
PacBio (PACB) announces that Novogene is set to use PACB's Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany.
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.